A randomized, open-Label, multicenter study assessing the effects of forced Exubera [inhaled insulin] dose titration on glycemic control in patients with suboptimally controlled type 2 diabetes on two or more oral antidiabetic agents

Trial Profile

A randomized, open-Label, multicenter study assessing the effects of forced Exubera [inhaled insulin] dose titration on glycemic control in patients with suboptimally controlled type 2 diabetes on two or more oral antidiabetic agents

Completed
Phase of Trial: Phase III

Latest Information Update: 25 Jul 2007

At a glance

  • Drugs Insulin (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Sponsors Pfizer
  • Most Recent Events

    • 25 Jul 2007 The expected completion date for this trial is now 1 Mar 2007.
    • 15 May 2007 Status change from in progress to completed.
    • 18 Jan 2007 Status changed from recruiting to in progress.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top